Sort by
Refine Your Search
-
Country
-
Employer
- Oak Ridge National Laboratory
- Pennsylvania State University
- Rutgers University
- The Ohio State University
- Texas A&M University
- University of Washington
- University of South Carolina
- University of North Carolina at Chapel Hill
- University of Arkansas
- University of Utah
- St Jude Children's Research Hospital
- University of Miami
- University of Kentucky
- University of Minnesota
- University of Oxford
- University of Texas at Tyler
- Central State University
- Kennesaw State University
- The University of Arizona
- University of Colorado
- Aarhus University
- Boise State University
- Washington University in St. Louis
- Anglia Ruskin University
- Anglia Ruskin University;
- Carnegie Mellon University
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Delaware State University
- Duke University
- Eli Lilly and Company
- Georgia Southern University
- IOCB Prague (Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences)
- Institute of Medical Biology Chinese Academy of Medical Sciences (IMBCAMS)
- McGill University
- Michigan State University
- Michigan Technological University
- Mossakowski Medical Research Institute, Polish Academy of Sciences
- NEW YORK UNIVERSITY ABU DHABI
- Nencki Institute of Experimental Biology
- Northeastern University
- Polymer Institute of the Slovak Academy of Sciences
- Princeton University
- Research Center for Molecular Medicine (CeMM), ÖAW
- Ryerson University
- Sandia National Laboratories
- University of California, Berkeley
- University of Dundee
- University of Kansas Medical Center
- University of New South Wales
- University of North Texas at Dallas
- University of Texas at Dallas
- University of Turku
- Université Paris Cité
- Virginia Tech
- Yale University
- Zintellect
- Łukasiewicz Research Network - Krakow Institute of Technology
- 47 more »
- « less
-
Field
-
; structure-based or computational drug design; ADME/PK or drug metabolism studies; biochemical or cell-based compound screening; and/or drug discovery for neurological or neurodegenerative diseases. A strong
-
(LHCb) physics program at the Large Hadron Collider (LHC). This group is actively participating in the design and realization of various hardware projects in support of the LHCb and electron ion proton
-
motivated and enthusiastic Postdoctoral Research Associate to contribute to research projects focused on neuroscience, G protein-coupled receptors (GPCRs), pharmacology and drug discovery. We are looking
-
literature for relevant innovation opportunities in data analyses, developing science around such opportunities, communicating such resulting science via professional computational repositories, conferences
-
development, fluorescence/imaging, flow cytometry, or related methods. Experience with computational drug discovery, molecular modeling, structure-based design, or analysis software such as MOE, AlphaFold/Boltz
-
approaches to cancer prevention, diagnosis, and therapies – providing tomorrow’s standard of care today. A Cancer-Free World Begins Here. The OSUCCC – James is the only cancer program in the United States that
-
computational chemistry. The candidate will be expected to fruitfully work with MCG chemists and physicists as well as make connections across the laboratory. Major Duties/Responsibilities: Design and execute
-
(if designated). If you close the browser or exit your application prior to submitting, the application process will be saved as a draft. You will be able to access and complete the application through “My Draft
-
drug test and participation in an ongoing random drug testing program. In addition, due the SCI, you may also be subject to random polygraph testing. About ORNL: As a U.S. Department of Energy (DOE
-
Screen reader users may encounter difficulty with this site. For assistance with applying, please contact [email protected] . If you have questions while submitting an application